|
|
Volumn 105, Issue 8, 1998, Pages 877-881
|
|
Delivery outcome after the use of acid-suppressing drugs in early pregnancy with special reference to omeprazole
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANALGESIC AGENT;
ANTACID AGENT;
ANTIASTHMATIC AGENT;
ANTIBIOTIC AGENT;
ANTIHISTAMINIC AGENT;
ANTITUSSIVE AGENT;
ANXIOLYTIC AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CHOLINERGIC RECEPTOR BLOCKING AGENT;
CIMETIDINE;
DECONGESTIVE AGENT;
FAMOTIDINE;
HISTAMINE H2 RECEPTOR ANTAGONIST;
LANSOPRAZOLE;
MISOPROSTOL;
NIZATIDINE;
NONSTEROID ANTIINFLAMMATORY AGENT;
OMEPRAZOLE;
PROTON PUMP INHIBITOR;
RANITIDINE;
ROXATIDINE;
SEX HORMONE;
ARTICLE;
CLINICAL TRIAL;
COHORT ANALYSIS;
CONGENITAL MALFORMATION;
DRUG USE;
FEMALE;
FIRST TRIMESTER PREGNANCY;
HUMAN;
MAJOR CLINICAL STUDY;
NEWBORN;
PRIORITY JOURNAL;
RISK ASSESSMENT;
TERATOGENESIS;
ABNORMALITIES, DRUG-INDUCED;
ADOLESCENT;
ADULT;
ANTI-ULCER AGENTS;
COHORT STUDIES;
FEMALE;
HISTAMINE H2 ANTAGONISTS;
HUMANS;
MATERNAL AGE;
MIDDLE AGED;
OMEPRAZOLE;
PREGNANCY;
PREGNANCY TRIMESTER, FIRST;
PROTON PUMPS;
SWEDEN;
|
|
EID: 0031709910
PISSN: 14700328
EISSN: 14710528
Source Type: Journal
DOI: 10.1111/j.1471-0528.1998.tb10233.x Document Type: Article |
|
Times cited : (59)
|
|
References (6)
|
